Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting No phase listed Observational

CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer

ClinicalTrials.gov ID: NCT05210283

Public ClinicalTrials.gov record NCT05210283. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 3:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

CORRECT-MRD II: Second Colorectal Cancer Clinical Validation Study to Predict Recurrence Using a Circulating Tumor DNA Assay to Detect Minimal Residual Disease

Study identification

NCT ID
NCT05210283
Recruitment status
Active, not recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Exact Sciences Corporation
Industry
Enrollment
1,017 participants

Conditions and interventions

Interventions

  • MRD Device

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 14, 2021
Primary completion
May 14, 2027
Completion
May 14, 2027
Last update posted
Jan 11, 2026

2021 – 2027

United States locations

U.S. sites
28
U.S. states
17
U.S. cities
28
Facility City State ZIP Site status
Facey Medical Group - Mission Hills - Endoscopy Center & Gastroenterology Mission Hills California 91345
Torrance Memorial Hunt Cancer Institute Torrance California 90505
University of Florida Division of Hematology & Oncology Gainesville Florida 32610
Mount Sinai Medical - Comprehensive Cancer Center Miami Beach Florida 33140
Mid Florida Cancer Centers Orange City Florida 32763
Edward Cancer Center Elmhurst Illinois 60126
Illinois Cancer Care Peoria Illinois 61615
Mercy Medical Center Cedar Rapids Iowa 52403
University of Kansas Cancer Center Westwood Kansas 66205
MedStar Georgetown Cancer Institute at MedStar Georgetown University Hospital Baltimore Maryland 21237
Meritus Center for Clinical Research Hagerstown Maryland 21742
University of Maryland St. Joseph Medical Center Towson Maryland 21093
Metro Minnesota Community Oncology Consortium (MMCORC) Saint Louis Park Minnesota 55426
Missouri Baptist Medical Center St Louis Missouri 63131
Atrium Health Levine Cancer Institute Charlotte North Carolina 28204
FirstHealth Outpatient Cancer Center Pinehurst North Carolina 28374
Atrium Health Wake Forest Baptist Medical Center Winston-Salem North Carolina 27157
Sanford Roger Maris Cancer Center Fargo North Dakota 58104
Columbus NCORP Columbus Ohio 43215
Interstate Medical Office Central Portland Oregon 97227
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232
Reading Hospital Hematology Oncology West Reading Pennsylvania 19611
Lankenau Medical Center Wynnewood Pennsylvania 19096
WellSpan York Cancer Center York Pennsylvania 17403
Primsa Health Cancer Institute Greenville South Carolina 29605
Sanford Cancer Center Sioux Falls South Dakota 57104
Ballad Health Cancer Center Kingsport Tennessee 37660
Marshfield Medical Center Weston Weston Wisconsin 54476

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05210283, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 11, 2026 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05210283 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →